Using long-acting injectable HIV treatment to help people released from jail stay healthy
Official title: Long-acting injectable antiretroviral treatment to improve HIV treatment among justice-involved persons being released to the community
Funded at Miriam Hospital · NIH-10894286 · Data updated 2026-11-12
This study is looking at how a special injectable HIV treatment given every four weeks can help people with HIV who are coming out of jail stay healthy and stick to their medication routine more easily.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miriam Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | September 30, 2022 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $231,115 |
| NIH project number | 5R34DA057165-03 |
| Project ID | NIH-10894286 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with HIV who are being released from incarceration and may have difficulty adhering to daily medication regimens.
✕Less likely to help
Patients who are not involved in the justice system or those who do not have HIV may not benefit from this research.
What this research studies
This research investigates how long-acting injectable antiretroviral treatment can improve health outcomes for individuals with HIV who are being released from incarceration. It focuses on the critical period of community re-entry, where these individuals often struggle to adhere to daily oral medications. By administering an injectable treatment every four weeks, the study aims to enhance adherence and viral suppression. The research will involve developing and testing a tailored protocol for this population in collaboration with local public safety departments.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced HIV transmission among justice-involved individuals.
How similar studies have gone: Other research has shown promise in using long-acting injectable treatments for HIV, indicating potential for success in this novel application.
Where this research is happening
-
Miriam Hospital
Providence, United States Active
Researchers
- Principal investigator: Beckwith, Curt G — Miriam Hospital
- Study coordinator: Beckwith, Curt G
Related research
Other NIH-funded projects on the same topics.
-
HIV drug resistance in the new ART era in Kenya
This project looks at how HIV drug resistance develops and is managed in Kenya as newer HIV medicines become common.
-
AI chatbot guides doxycycline PEP for MSM
A pilot study tests an AI chatbot to help men who have sex with men use doxycycline after exposure to prevent STIs.
-
HIV Drug Resistance in the ART Era in Kenya
A study looking at how HIV drug resistance emerges and changes as treatment options evolve in Kenya, with an eye toward improving care where monitoring is limited.
-
Adapting Future Thinking to Help Weight Loss
A patient-friendly program tests if imagining future outcomes can help people with obesity make better food choices and lose weight.
-
Weight-loss maintenance: using real-time data to tailor behavioral support
A weight-management program uses real-time prompts and personalized support to help adults keep weight off after initial loss.
-
Childhood adversity and teen substance use: how mood and feelings influence risky choices
A psychologist is studying how tough early life experiences affect teens’ chances of using substances, focusing on how feelings and mood may link adversity to later use.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.